CR7456A - DERMIC IMPLANT - Google Patents

DERMIC IMPLANT

Info

Publication number
CR7456A
CR7456A CR7456A CR7456A CR7456A CR 7456 A CR7456 A CR 7456A CR 7456 A CR7456 A CR 7456A CR 7456 A CR7456 A CR 7456A CR 7456 A CR7456 A CR 7456A
Authority
CR
Costa Rica
Prior art keywords
dermic
implant
nasogeneous
wrinkles
grooves
Prior art date
Application number
CR7456A
Other languages
Spanish (es)
Inventor
Kirkorian Joel
Original Assignee
Establishment Biotech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Establishment Biotech Sa filed Critical Establishment Biotech Sa
Priority to CR7456A priority Critical patent/CR7456A/en
Publication of CR7456A publication Critical patent/CR7456A/en

Links

Landscapes

  • Prostheses (AREA)

Abstract

Se refiere a un producto utilizado por el sector medico quirurgico, cncretamente para el tratamiento de arrugas, surcos nasogeneanos y lineas de expresion.It refers to a product used by the surgical medical sector, specifically for the treatment of wrinkles, nasogeneous grooves and expression lines.

CR7456A 2004-09-02 2004-09-02 DERMIC IMPLANT CR7456A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR7456A CR7456A (en) 2004-09-02 2004-09-02 DERMIC IMPLANT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR7456A CR7456A (en) 2004-09-02 2004-09-02 DERMIC IMPLANT

Publications (1)

Publication Number Publication Date
CR7456A true CR7456A (en) 2005-11-03

Family

ID=44839231

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7456A CR7456A (en) 2004-09-02 2004-09-02 DERMIC IMPLANT

Country Status (1)

Country Link
CR (1) CR7456A (en)

Similar Documents

Publication Publication Date Title
CY1119582T1 (en) HYDRAULIC INSULIN PREPARATIONS CONTAINING Methionine
CY1113108T1 (en) LEVODOPA BASIC PRODUCT, HIS COMPOSITIONS, AND USES
CY1116927T1 (en) TETROHYDROCANNABINOL PRODUCTS, COMPOSITIONS CONTAINING TETHYROCANNABINOL PRODUCTS AND METHODS OF USE
EA200801138A1 (en) Use of flibanserine for the treatment of sexual appetite disorders in the preclinical period
CL2007002382A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the treatment of skin cancer.
MX2019011117A (en) B7-h3 antibody, antigen-binding fragment thereof and medical use thereof.
EA200802208A1 (en) APPLICATION OF FLIBANSTERIN FOR THE TREATMENT OF DISEASES OF THE SEXUAL TREATMENT IN THE POST-CLIMACTERNIC PERIOD
UA105210C2 (en) Anti-cancer vaccine and use thereof
CY1112320T1 (en) TAPENDADOL TITLE
ES2422739T3 (en) Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-, comprising UCB MSC
CY1116160T1 (en) Pediatric Acute Acute Lymphoblastic Leukemia Treatment
CY1113766T1 (en) INDOLIDONES PRODUCTS FOR THE TREATMENT OR PREVENTION OF DISEASES
MX2009013970A (en) Fibrin gel for controlled release of pdgf and uses thereof.
UA94734C2 (en) THERAPEUTIC ANTIBODIY WHICH BINDS TO b-AMYLOID PEPTIDE
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
AR079160A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A STRONTIUM SALT, VITAMIN D AND A CYCLODEXTRINE
EA200801717A1 (en) LOCAL APPLICATION COMPOSITION FOR SKIN CARE, PRODUCT ON ITS BASIS AND METHOD OF TREATMENT
CY1117603T1 (en) LIXISENATIDE AS AN ADDITION TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES
CY1112738T1 (en) A COMBINED COMPOSITION CONTAINING Ibuprofen And Paracetamol
CY1122198T1 (en) MEDICAL PRODUCT AND THERAPY
CY1115725T1 (en) UNIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF BETA-AMYLOIDIC DISEASES AND CONCLUSIONS
BR112015022161A2 (en) prostamide-containing intraocular implant
MX2022014792A (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same.
DK1869185T3 (en) Conjugate with P21 protein for cancer treatment
MX2013008654A (en) Combinations.